For research use only. Not for therapeutic Use.
KI696(Cat No.:I020276)is an investigational small molecule compound studied for its potential therapeutic applications, particularly in cancer treatment. It functions as an inhibitor of a specific protein or enzyme involved in cancer cell proliferation, survival, or metastasis. KI696 is believed to interfere with molecular signaling pathways that are dysregulated in cancer cells, thereby suppressing tumor growth. Preclinical studies have shown promising results in reducing tumor cell viability and enhancing the effectiveness of other cancer therapies. Ongoing research aims to evaluate its safety, pharmacokinetics, and efficacy in clinical trials for oncology.
Catalog Number | I020276 |
CAS Number | 1799974-70-1 |
Molecular Formula | C₂₈H₃₀N₄O₆S |
Purity | ≥95% |
Target | Keap1-Nrf2 |
IUPAC Name | (3S)-3-(7-methoxy-1-methylbenzotriazol-5-yl)-3-[4-methyl-3-[[(4R)-4-methyl-1,1-dioxo-3,4-dihydro-5,1lambda6,2-benzoxathiazepin-2-yl]methyl]phenyl]propanoic acid |
InChI | InChI=1S/C28H30N4O6S/c1-17-9-10-19(22(14-27(33)34)20-12-23-28(25(13-20)37-4)31(3)30-29-23)11-21(17)16-32-15-18(2)38-24-7-5-6-8-26(24)39(32,35)36/h5-13,18,22H,14-16H2,1-4H3,(H,33,34)/t18-,22+/m1/s1 |
InChIKey | ZDNGJXBUEQNFBQ-GCJKJVERSA-N |
SMILES | C[C@@H]1CN(S(=O)(=O)C2=CC=CC=C2O1)CC3=C(C=CC(=C3)[C@H](CC(=O)O)C4=CC5=C(C(=C4)OC)N(N=N5)C)C |